Involvement of the proteasome and caspase activation in hippocampal long-term depression induced by the serine protease subtilisin

Neuroscience

Volumn 231, Issue , 2013, Pages 233-246

  Forrest, C M ^a   Darlington, L G ^b   Stone, T W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b EPSOM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Caspase 3; Long term depression; LTD; Proteasome; Subtilisin; Synaptic plasticity

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE; CASPASE 9; CASPASE INHIBITOR; CELL PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROCASPASE 3; PROTEASOME; SUBTILISIN; UNCLASSIFIED DRUG; UNCOCORDINATED 5H3 PROTEIN; VESSICLE ASSOCIATED MEMBRANE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME METABOLISM; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STRATUM RADIATUM;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; CASPASE 3; CASPASE 9; CASPASE INHIBITORS; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LEUPEPTINS; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MALE; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUBTILISINS;

EID: 84872348648     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.029     Document Type: Article

References (47)

1. Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev 1999, 29:83-120.
2. Anwyl R. Induction and expression mechanisms of postsynaptic NMDA receptor-independent homosynaptic long-term depression. Prog Neurobiol 2006, 78:17-37.
3. Behnisch T., Matsushita S., Knopfel T. Imaging of gene expression during long-term potentiation. NeuroReport 2004, 15:2039-2043.
4. Bingol B., Schuman E.M. A proteasome-sensitive connection between PSD-95 and GluR1 endocytosis. Neuropharmacology 2004, 47:755-763.
5. Bulat N., Widmann C. Caspase substrates and neurodegenerative diseases. Brain Res Bull 2009, 80:251-267.
6. Cai F., Frey J.U., Sannad P.P., Behnisch T. Protein degradation by the proteasome is required for synaptic tagging and the heterosynaptic stabilization of hippocampal late-phase long-term potentiation. Neuroscience 2010, 169:1520-1526.
7. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999, 58:167-190.
8. Chowdhury I., Tharakan B., Bhat G.K. Caspases - an update. Comp Biochem Physiol B: Biochem Mol Biol 2008, 151:10-27.
9. Citri A., Soler-Llavina G., Bhattacharyya S., Malenka R.C. N-methyl-d-aspartate receptor- and metabotropic glutamate receptor-dependent long-term depression are differentially regulated by the ubiquitin-proteasome system. Eur J Neurosci 2009, 30:1443-1550.
10. Collingridge G.L., Peineau S., Howland J.G., Wang Y.T. Long-term depression in the CNS. Nat Rev Neurosci 2010, 11:459-473.
11. Crawford E.D., Wells J.A., Kornberg R.D., Raetz C.R.H., Rothman J.E., Thorner J.W. Caspase substrates and cellular remodelling. Annu Rev Biochem 2011, 80:1055-1087.
12. Csordas A., Wick G., Bernhard D. Hydrogen peroxide-mediated necrosis induction in HUVECs is associated with an atypical pattern of caspase-3 cleavage. Exp Cell Res 2006, 312:1753-1764.
13. D'Amelio M., Cavallucci V., Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ 2010, 17:1104-1114.
14. Duenstl G., Welland T., Schlaeger C., Nuessler A., Kuenstle G., Wendel A. Activation of an alternative death receptor-induced signaling pathway in human hepatocytes under caspase arrest. Arch Biochem Biophys 2007, 462:140-149.
15. Feinstein-Rotkopf Y., Arama E. Can't live without them, can live with them: roles of caspases during vital cellular processes. Apoptosis 2009, 14:980-995.
16. Fellows E., Gil-Parrado S., Jenne D.E., Kurschus F.C. Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program. Blood 2007, 110:544-552.
17. Forcet C., Ye X., Granger L., Corset V., Shin H., Bredesen D.E., Mehlen P. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci U S A 2001, 98:3416-3421.
18. Forrest C.M., Addae J.I., Murthy S., Darlington L.G., Morris B.J., Stone T.W. Molecular changes associated with hippocampal long-lasting depression induced by the serine protease subtilisin-A. Eur J Neurosci 2011, 34:1241-1253.
19. Gerace E., Scartabelli T., Forementini L., Landucci E., Moroni F., Chiarugi A., Pellegrini-Giampetro D.E. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal models of ischemic tolerance. Eur J Neurosci 2012, 36:1993-2005.
20. Gillardon F., Kiprianova I., Sandkuhler J., Hossmann K.A., Spranger M. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience 1999, 93:1219-1222.
21. Gunn-Moore F.J., Tavare J.M. Apoptosis of cerebellar granule cells induced by serum withdrawal, glutamate or beta-amyloid, is independent of Jun kinase or p38 mitogen activated protein kinase activation. Neurosci Lett 1998, 250:53-56.
22. Hamilton A.M., Oh W.C., Vega-Ramirez H., Stein I.S., Hell J.W., Patrick G.N., Zito K. Activity-dependent growth of new dendritic spines is regulated by the proteasome. Neuron 2012, 74:1023-1030.
23. Hoffmann J.C., Pappa A., Krammer P.H., Lavrik I.N. A new C-terminal cleavage product of procaspase-8, p30, defines an alternative pathway of procaspase-8 activation. Mol Cell Biol 2009, 29:4431-4440.
24. Jo J., Whitcomb D.J., Olsen K.M., Kerrigan T.L., Lo S.C., Bru-Mercier G., Dickinson B., Scullion S., Sheng M., Collingridge G., Cho K. Aβ1-42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat Neurosci 2011, 14:545-547.
25. Karpova A., Mikhaylova M., Ulrich T., Knopfel T., Behnisch T. Involvement of protein synthesis and degradation in long-term potentiation of Schaffer collateral CA1 synapses. J Neurosci 2006, 26:4949-4955.
26. Kemp A., Manahan-Vaughan D. Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition. Proc Natl Acad Sci U S A 2004, 101:8192-8197.
27. Kemp N., McQueen J., Faulkes S., Bashir Z.I. Different forms of LTD in the CA1 region of the hippocampus: role of age and stimulus protocol. Eur J Neurosci 2000, 12:360-366.
28. Kunstle G., Leist M., Uhlig S., Revesz L., Feifel R., MacKenzie A., Wendel A. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 1997, 55:5-10.
29. Kuranaga E. Caspase signaling in animal development. Dev Growth Differ 2011, 53:137-148.
30. Larson J., Wong D., Lynch G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res 1986, 368:347-350.
31. Lee D.H., Goldberg A.L. Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae. Mol Cell Biol 1998, 18:30-38.
32. Li J., Yuan J. Caspases in apoptosis and beyond. Oncogene 2008, 27:6194-6206.
33. Li Z., Jo J., Jie-Min J., Lo S.-C., Whitcomb D.J., Jiao S., Cho K., Sheng M. Caspase-3 activation via mitochondria is required for LTD and AMPA receptor internalisation. Cell 2010, 141:859-871.
34. MacGregor D.G., Mallon A.P., Harvey A.L., Young L., Nimmo H.G., Stone T.W. Group S8A serine proteases, including a novel enzyme cadeprin, induce long-lasting, metabotropic glutamate receptor-dependent, synaptic depression in rat hippocampal slices. Eur J Neurosci 2007, 26:1870-1880.
35. Maelfait J., Beyaert R. Non-apoptotic functions of caspase-8. Biochem Pharmacol 2008, 76(Suppl. 1):1365-1373.
36. Mulkey R.M., Malenka R.C. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 1992, 9:967-975.
37. O'Connell A.R., Holohan C., Torriglia A., Lee B.F., Stenson-Cox C. Characterization of a serine protease-mediated cell death program activated in human leukemia cells. Exp Cell Res 2006, 312:27-39.
38. Ortega A., Moran J. Role of cytoskeleton proteins in the morphological changes during apoptotic cell death of cerebellar granule neurons. Neurochem Res 2011, 36:93-102.
39. Perez-de-la-Cruz V., Elinos-Calderon D., Carrillo-Mora P., Silva-Adaya D., Konigsberg M., Moran J., Ali S.F., Elena-Chanez-Cardenas M., Perez-de-la-Cruz G., Santamaria A. Time-course correlation of early toxic events in three models of striatal damage: modulation by protease inhibition. Neurochem Int 2010, 56:834-842.
40. Shepherd J.D., Huganir R.L. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 2007, 23:613-643.
41. Shultz J.C., Goehe R.W., Murudkar C.S., Wijesinghe D.S., Mayton E.K., Massiello A., Hawkins A.J., Mukerjee P., Pinkerman R.L., Park M.A., Chalfant C.E. SRSF1 regulates the alternative splicing of caspase-9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol Cancer Res 2011, 9:889-900.
42. Shultz J.C., Goehe R.W., Wijesinghe D.S., Murudkar C., Hawkins A.J., Shay J.W., Minna J.D., Chalfant C.E. Alternative splicing of caspase-9 is modulated by the phosphoinositide 3-kinase/akt pathway via phosphorylation of SRp30a. Cancer Res 2010, 70:9185-9196.
43. Stefanis L., Park D.S., Friedman W.J., Greene L.A. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J Neurosci 1999, 19:6235-6247.
44. Tsokas P., Grace E.A., Chan P., Ma T., Sealfon S.C., Iyengar R., Landau E.M., Blitzer R.D. Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation. J Neurosci 2005, 25:5833-5843.
45. Valanne A., Malmi P., Appelblom H., Niemela P., Soukka T. A dual-step fluorescence resonance energy transfer-based quenching assay for screening of caspase-3 inhibitors. Anal Biochem 2008, 375:71-81.
46. Yi C.H., Yuan J. The Jekyll and Hyde functions of caspases. Dev Cell 2009, 16:21-34.
47. Zhang M., Ling Y., Yang C.-Y., Liu H., Wang R., Wu X., Ding K., Zhu F., Griffith B.N., Mohammad R.M., Wang S., Yang D. A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells. Ann Hematol 2007, 86:471-481.